Ibodutant

DB12042InvestigationalSmall molecule

Ibodutant has been used in trials studying the treatment of Irritable Bowel Syndrome and Irritable Bowel Syndrome With Diarrhea.

Chemical structure of Ibodutant
Mechanism
Curator reviewed
Formula / weight
C37H48N4O4S · 644.88 g/mol (avg)

Resolves to

Compound
UNII1H7RSQ28BJCAS522664-63-7ChEMBLCHEMBL266125PubChem11527495
Structure
InChIKeyYQYSVMKCMIUCHY-WJOKGBTCSA-NSMILESCC1=CC=C2C=C(SC2=C1)C(=O)NC1(CCCC1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)NCC1CCN(CC2CCOCC2)CC1
Targets
P21452TACR2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ibodutant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In